Oladele Simeon Olatunya

Dr. Oladele Simeon Olatunya

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2020 in Expert Review of Anti-infective Therapy
Verified
Journal Article
Closed access
ABAdefunke O Babatola
Adefunke O Babatola
JFJoseph Olusesan Fadare
Joseph Olusesan Fadare
OOOladele Simeon Olatunya
Oladele Simeon Olatunya
ROReginald Obiako
Reginald Obiako
OEOkezie Enwere
Okezie Enwere
BGBrian Godman
Brian Godman
We assessed the knowledge of, attitude toward antimicrobial resistance (AMR) and practice of antimicrobial stewardship (AMS) among physicians in Nigeria to provide future guidance to the Nigerian N...

1 November 2015 in ClinicoEconomics and Outcomes Research
Verified
Journal Article
Open access
PDF file
OOOladele Simeon Olatunya
Oladele Simeon Olatunya
OOOlatunde Ogundare
Olatunde Ogundare
JFJoseph Olusesan Fadare
Joseph Olusesan Fadare
OOOludare Oluwayemi
Oludare Oluwayemi
OAOyinkansola Tolulope Agaja
Oyinkansola Tolulope Agaja
OAOdunayo Aderiye
Odunayo Aderiye
Background: Studies on economic impact of sickle cell disease (SCD) are scanty despite its being common among children in developing countries who are mostly Africans. Objective: To determine the financial burden of SCD on households in Ado Ekiti, Southwest Nigeria. Methods: A longitudinal and descriptive study of household expenditures on care of 111 children with SCD managed at the pediatric hematology unit of the Ekiti State University Teaching Hospital was conducted between January and December 2014. Results: There were 64 male and 47 female children involved, aged between 15 and 180 months. They were from 111 households, out of which only eight (7.2%) were enrolled under the National Health Insurance Scheme. The number of admissions and outpatients' consultations ranged from 1 to 5 and 1 to 10 per child, respectively. Malaria, vaso-occlusive crisis, and severe anemia were the leading comorbidities. The monthly household income ranged between ₦12,500 and ₦330,000 (US$76 and US$2,000) with a median of ₦55,000 (US$333), and health expenditure ranged between ₦2,500 and ₦215,000 (US$15 and US$1,303) with a mean of ₦39,554±35,479 (US$240±215). Parents of 63 children lost between 1 and 48 working days due to their children's ill health. Parents of 23 children took loans ranging between ₦6,500 and ₦150,000 (US$39 and US$909) to offset hospital bills. The percentage of family income spent as health expenditure on each child ranged from 0.38 to 34.4. Catastrophic health expenditure (when the health expenditure >10% of family income) occurred in 23 (20.7%) households. Parents who took loan to offset hospital bills, low social class, and patients who took ill during the study period significantly had higher odds for catastrophic health expenditure (95% confidence interval [CI] 5.399–87.176, P=0.000; 95% CI 2.322–47.310, P=0.002; and 95% CI 1.128–29.694, P=0.035, respectively). Conclusion: SCD poses enormous financial burden on parents and households.

6 September 2019 in Annals of Hematology
Verified
Journal Article
Closed access
PDF file
OOOladele Simeon Olatunya
Oladele Simeon Olatunya
CLCarolina Lanaro
Carolina Lanaro
ALAna Leda Longhini
Ana Leda Longhini
CPCarla Fernanda Franco Penteado
Carla Fernanda Franco Penteado
KFKleber Y. Fertrin
Kleber Y. Fertrin
FCFernando Ferreira Costa
Fernando Ferreira Costa

1 September 2012 in The Journal of Alternative and Complementary Medicine
Verified
Journal Article
Closed access
OOOladele Simeon Olatunya
Oladele Simeon Olatunya
AOAyomadewa M. Olatunya
Ayomadewa M. Olatunya
HAHenry C. Anyabolu
Henry C. Anyabolu
EAEbun A. Adejuyigbe
Ebun A. Adejuyigbe
OOOyeku A. Oyelami
Oyeku A. Oyelami
Background: Ten (10) young women diagnosed with human immunodeficiency virus (HIV) infection in the Wesley Guild Hospital Ilesa, a unit of Obafemi Awolowo University Teaching Hospital, Ile Ife, Osun State, Nigeria who did not meet the national criteria for the use of antiretroviral drugs were managed with 30–40 mL of aloe vera (Aloe barbadensis miller) gruel daily. Methods: Their CD4 counts, general improvement, and physical well-being (including weight gain) were monitored over a 1-year period. The findings were compared with those of 20 age- matched controls who were on antiretroviral drugs. One (1) patient who reacted badly to antiretroviral drug switched over to aloe vera. Results: The average weight gain among those on aloe vera was 4.7 kg compared to 4.8 kg by those on antiretroviral drug (p=0.916). The average rise in CD4 count among them was 153.7 cells/μL compared to 238.85 cells/μL among the controls (p=0.087). There was no significant side effect(s) in either group except in the 1 patient who switched over from antiretroviral drugs to aloe vera gruel. Conclusions: These preliminary data suggest that consumption of aloe vera may be of help to HIV-infected individuals in the tropics, given its availability and inexpensiveness.

12 June 2022 in Acta Paediatrica
Verified
Journal Article
Closed access
Eva JörgensenEva Jörgensen
Eva Jörgensen
DKDonna Koller
Donna Koller
SRShanti Raman
Shanti Raman
OOOladele Simeon Olatunya
Oladele Simeon Olatunya
OAOsamagbe Asemota
Osamagbe Asemota
AOAngela Anene Okolo
Angela Anene Okolo

20 August 2018 in Journal of Clinical Laboratory Analysis
Verified
Journal Article
Closed access
PDF file
OOOladele Simeon Olatunya
Oladele Simeon Olatunya
DADulcineia M. Albuquerque
Dulcineia M. Albuquerque
AAAdekunle Adekile
Adekunle Adekile
FCFernando F. Costa
Fernando F. Costa